…density over 52 weeks with placebo, but it remained stable with nintedanib. Among patients who had ILD progression (n=11), there was a num…
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Articles mentioning drugs
10,506 articles · page 258 of 876…5%), no readmissions Documented follow-up 34 (91.9%) Conclusion Dalbavancin enabled safe discharge and admission avoidance in selected cell…
…ibiting respiratory complex I, contributing to adverse effects. Risperidone, a dopamine D2/serotonin 5-HT2 antagonist, and aripiprazole, a …
…group, patients achieving a clinical complete response (cCR) to camrelizumab combined with neoCRT will undergo active surveillance, while th…
…nders.Period of diagnosis, diagnosis 1999–2004 versus 1996–1998.a-HTT, anti-hypertensive treatment; BMI, body mass index; DBP, diasto…
…Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available…
…. 93% of patients were on beta blocker. 74% were on MRA, 74% on SGLT2i. 6 patients were readmitted to hospital from VW. The median NT …
…t 6 months of treatment. Younger participants, those prescribed weight management medications, and those who received a digital welcome letter before admissi…
…ative topical antiseptic prior to further movement. Early IV/PO cefazolin is reinforced.Role 3: Comprehensive hospital careDaily whole-bo…
…ng in people aged over 50 years. Recent studies have shown that tocilizumab (TCZ), an anti-IL-6 receptor monoclonal antibody, is remarkably…
…efined information on joint effects of occupational exposure to hexavalent chromium (Cr(VI)) and smoking on lung-cancer risk.Material and Methods This analy…
…he active Tecar therapy group (active device group) or the sham Tecar therapy group (placebo device group). The women undergo one Tec…